サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1675397

一塩基多型（SNP）ジェノタイピング市場：技術別、用途別、地域別、2025-2033年

Single Nucleotide Polymorphism Genotyping Market Report by Technology, Application, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
一塩基多型（SNP）ジェノタイピング市場：技術別、用途別、地域別、2025-2033年
出版日: 2025年03月01日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の一塩基多型（SNP）ジェノタイピング市場規模は、2024年に113億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに423億米ドルに達し、2025年から2033年にかけて15.00%の成長率（CAGR）を示すと予測しています。遺伝子型の研究開発活動の発展、個別化医療や新規ドラッグデリバリーシステムに対する需要の高まり、動植物飼料における遺伝子解析需要の増加が、市場を牽引する主な要因となっています。

一塩基多型（SNP）ジェノタイピングは、デオキシリボ核酸（DNA）配列内の特定の位置を調べることにより、個体間の遺伝的変異を同定・分析するために考案された技術です。これは、個人のDNA中の特定のSNP部位に存在する特定のヌクレオチドを決定することを含みます。ポリメラーゼ連鎖反応（PCR）やDNA塩基配列決定などの高度な分子生物学的技術に依存しており、PCRによってSNPを含むDNA断片を増幅し、増幅されたDNAを直接塩基配列決定するか、マイクロアレイや対立遺伝子特異的PCRなどの他の方法を用いてSNP部位のヌクレオチドを決定します。集団遺伝学、移動パターン、進化の歴史を理解するのに役立ちます。また、薬剤に対する反応を決定したり、疾患感受性を予測したり、特定の遺伝子プロファイルに合わせた治療を行う上で重要な役割を果たしています。SNPジェノタイピングは、複雑な疾患の遺伝的基盤の研究、遺伝的危険因子の同定、および強化された診断ツールの開発に研究者によって使用されています。

一塩基多型（SNP）ジェノタイピング市場の動向：

現在、さまざまな疾患の診断ツールや効果的な治療法の開発における遺伝子型の研究開発活動やバイオインフォマティクスの高まりを背景に、SNPジェノタイピングの需要が増加していることは、市場の成長を支える重要な要因の一つです。さらに、がん、心血管、アルツハイマー病、喘息など、様々なヒト疾患の病因におけるSNPジェノタイピングの利用が拡大していることも、良好な市場見通しをもたらしています。このほか、遺伝的関係の確立、父子関係の紛争解決、犯罪捜査の支援などを目的としたSNPジェノタイピングの需要が世界中で高まっています。このことは、盛んな医療業界とともに市場の成長を促進しています。さらに、個別化医療と新規ドラッグデリバリーシステムのためのパイプラインの増加によるファーマコゲノミクスの需要の増加が、市場の成長を強化しています。これとは別に、農業バイオテクノロジー、診断研究、製薬、ファーマコゲノミクス、動物・家畜繁殖などのライフサイエンス分野におけるSNPジェノタイピングの数多くの技術が、市場の成長に寄与しています。これに伴い、世界中で糖尿病、心血管疾患、がんの有病率が増加しており、市場にプラスの影響を与えています。さらに、動物や植物の飼料原料における遺伝子解析の需要の高まりが、市場の成長を後押ししています。

本レポートで扱う主な質問

  • 世界の一塩基多型（SNP）ジェノタイピング市場はこれまでどのように推移してきたか？
  • 世界の一塩基多型（SNP）ジェノタイピング市場における市場促進要因、抑制要因、機会は何か？
  • 一塩基多型（SNP）ジェノタイピングの世界市場において、それぞれの促進要因、抑制要因、機会が与える影響は？
  • 主要な地域市場は？
  • 一塩基多型（SNP）ジェノタイピング市場で最も魅力的な国は？
  • 技術別の市場内訳は？
  • 一塩基多型（SNP）ジェノタイピング市場で最も魅力的な技術はどれか？
  • 用途別の市場内訳は？
  • 一塩基多型（SNP）ジェノタイピング市場で最も魅力的な用途はどれか？
  • 世界の一塩基多型（SNP）ジェノタイピング市場の競合構造は？
  • 世界の一塩基多型（SNP）ジェノタイピング市場の主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の一塩基多型（SNP）ジェノタイピング市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：技術別

  • TaqMan
  • MassARRAY
  • SNP遺伝子チップ
  • その他

第7章 市場内訳：用途別

  • 動物遺伝学
  • 植物改良
  • 診断研究
  • 医薬品・薬理ゲノミクス
  • 農業バイオテクノロジー
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第9章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Eurofins Genomics（Eurofins Scientific SE）
    • Illumina Inc.
    • Integrated DNA Technologies, Inc.（Danaher Corporation）
    • LGC Limited
    • PREMIER Biosoft
    • Promega Corporation
    • QIAGEN N.V
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Major Drivers and Challenges
  • Figure 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: China: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: China: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: India: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: India: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: France: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: France: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Country (in %), 2024
  • Figure 75: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Drivers, Restraints, and Opportunities
  • Figure 77: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Value Chain Analysis
  • Figure 78: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Competitive Structure
  • Table 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Players
目次
Product Code: SR112025A8146

The global single nucleotide polymorphism (SNP) genotyping market size reached USD 11.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 42.3 Billion by 2033, exhibiting a growth rate (CAGR) of 15.00% during 2025-2033. The growing genotype research and development activities, rising demand for personalized medicine and novel drug delivery systems, and increasing demand for genetic analysis in animal and plant feedstock represent some of the key factors driving the market.

Single nucleotide polymorphism (SNP) genotyping is a technique designed to identify and analyze genetic variations among individuals by examining specific locations within their deoxyribonucleic acid (DNA) sequence. It involves determining the specific nucleotide present at a particular SNP site in the DNA of an individual. It relies on advanced molecular biology techniques, such as polymerase chain reaction (PCR) and DNA sequencing, wherein PCR amplifies the DNA segment containing the SNP, and then the nucleotide at the SNP site is determined either by directly sequencing the amplified DNA or using other methods like microarrays or allele-specific PCR. It aids in understanding population genetics, migration patterns, and evolutionary history. It plays a crucial role in determining response to medications, predicting disease susceptibility, and tailoring treatments to specific genetic profiles. SNP genotyping is used by researchers to study the genetic basis of complex diseases, identify genetic risk factors, and develop enhanced diagnostic tools.

Single Nucleotide Polymorphism (SNP) Genotyping Market Trends:

At present, the increasing demand for SNP genotyping on account of the rising genotype research and development activities and bioinformatics in the development of diagnostic tools or effective therapeutics for various diseases represents one of the crucial factors supporting the growth of the market. In addition, the growing utilization of SNP genotyping in the etiology of various human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, is offering a favorable market outlook. Besides this, there is a rise in the demand for SNP genotyping to establish genetic relationships, resolve paternity disputes, and assist in criminal investigations around the world. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the increasing demand for pharmacogenomics due to the rising pipeline for personalized medicine and novel drug delivery systems is strengthening the growth of the market. Apart from this, numerous technologies of SNP genotyping in the life science field, such as agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics, and animal and livestock breeding, are contributing to the growth of the market. In line with this, the growing prevalence of diabetes, cardiovascular diseases, and cancer across the globe is positively influencing the market. Furthermore, the rising demand for genetic analysis in animal and plant feedstock is bolstering the growth of the market.

Key Market Segmentation:

Technology Insights:

  • TaqMan SNP Genotyping
  • Massarray SNP Genotyping
  • SNP GeneChip Arrays
  • Others

Application Insights:

  • Animal Genetics
  • Plant Improvement
  • Diagnostic Research
  • Pharmaceuticals and Pharmacogenomics
  • Agricultural Biotechnology
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for single nucleotide polymorphism (SNP) genotyping. Some of the factors driving the North America single nucleotide polymorphism (SNP) genotyping market included favorable government policies towards proper diagnosis, increasing screening and treatment of fatal diseases, availability of enhanced research and development (R&D) facilities, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global single nucleotide polymorphism (SNP) genotyping market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Eurofins Genomics (Eurofins Scientific SE), Illumina Inc., Integrated DNA Technologies, Inc. (Danaher Corporation), LGC Limited, PREMIER Biosoft, Promega Corporation, QIAGEN N.V, Roche Holding AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global single nucleotide polymorphism (SNP) genotyping market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global single nucleotide polymorphism (SNP) genotyping market?
  • What is the impact of each driver, restraint, and opportunity on the global single nucleotide polymorphism (SNP) genotyping market?
  • What are the key regional markets?
  • Which countries represent the most attractive single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the competitive structure of the global single nucleotide polymorphism (SNP) genotyping market?
  • Who are the key players/companies in the global single nucleotide polymorphism (SNP) genotyping market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Single Nucleotide Polymorphism (SNP) Genotyping Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 TaqMan SNP Genotyping
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Massarray SNP Genotyping
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 SNP GeneChip Arrays
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Animal Genetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Plant Improvement
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diagnostic Research
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pharmaceuticals and Pharmacogenomics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Agricultural Biotechnology
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Eurofins Genomics (Eurofins Scientific SE)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Illumina Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 LGC Limited
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 PREMIER Biosoft
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Promega Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 QIAGEN N.V
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Roche Holding AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Thermo Fisher Scientific Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.